TESSy

TESSy
Name	TESSy
Type	Surveillance database
Founded	1990s
Owner	European Centre for Disease Prevention and Control
Location	Stockholm, Sweden
Languages	English

TESSy The European Surveillance System (TESSy) is a centralized public health surveillance database operated by the European Centre for Disease Prevention and Control in Stockholm, designed to collect, validate, and analyse communicable disease data across European Union and European Economic Area countries. It supports epidemiological monitoring, outbreak detection, and vaccine-preventable disease assessment by aggregating case notifications, laboratory results, and vaccination records from national public health institutes such as Robert Koch Institute, Agence nationale de santé publique, and Istituto Superiore di Sanità. TESSy interfaces with multinational initiatives including World Health Organization programmes, European Commission health policies, and collaborative projects with agencies like European Medicines Agency and Joint Research Centre.

Overview

TESSy functions as a pan-European repository for standardized case-based and aggregated data related to infectious diseases, facilitating comparisons across member states such as France, Germany, Italy, Spain, Poland, Sweden, Netherlands, Belgium, Portugal, and Greece. It enables integrated outputs for surveillance products like weekly and annual epidemiological reports produced in cooperation with entities including WHO Regional Office for Europe, European Influenza Surveillance Network, European Vaccine Initiative, and national reference laboratories such as Statens Serum Institut. The system supports disease-specific modules covering pathogens like SARS-CoV-2, Influenza A virus subtype H1N1, Measles virus, Rubella virus, Neisseria meningitidis, and Salmonella enterica.

History and Development

Development traces to early electronic reporting efforts in the 1990s under coordination by the European Commission and regional networks such as Eurosurveillance. Formal consolidation occurred after establishment of the European Centre for Disease Prevention and Control in 2005, with iterative upgrades following outbreaks including the 2009 swine flu pandemic, the 2014–2016 Ebola epidemic in West Africa, and the COVID-19 pandemic. Major milestones involved adoption of standardized case definitions from bodies like World Health Organization and implementation of interoperable messaging standards influenced by projects connected to E-Health Network and European Interoperability Framework.

Structure and Components

Architecturally, the system comprises a secure central database, web-based submission interfaces, validation tools, analytic modules, and reporting dashboards integrated with statistical packages used by institutes such as European Centre for Disease Prevention and Control analysts and national surveillance teams including Public Health England (now UK Health Security Agency), Health Protection Surveillance Centre (Ireland), and Instituto de Salud Carlos III. Components include disease-specific datasets, metadata catalogues, laboratory data fields compatible with reference centres like European Reference Laboratory Network for Influenza, and vaccination modules aligned with initiatives such as European Vaccination Week. Technical frameworks draw on standards promoted by International Organization for Standardization and data modeling influenced by projects linked to Eurostat and Joint Research Centre.

Data Collection and Management

Data flows into the system via national nodes—national public health institutes and laboratories in countries like Romania, Hungary, Czech Republic, Slovakia, Lithuania, and Latvia—using agreed schemas, secure transmission protocols, and routine validation. Management practices include case-based reporting, aggregated counts, laboratory-confirmed case linkage, and longitudinal vaccination histories enabling trend analyses reminiscent of research from European Journal of Epidemiology and surveillance outputs coordinated with WHO Regional Office for Europe. Quality assurance relies on data cleaning, deduplication, and harmonization guided by technical guidance developed in collaboration with institutions such as European Centre for Disease Prevention and Control subject-matter experts and national epidemiologists.

Uses and Applications

The repository underpins outbreak detection, situational awareness, vaccine effectiveness studies, and policy-making support for decision-makers in European Commission directorates and national ministries of health in capitals including Berlin, Paris, Rome, Madrid, and Warsaw. Researchers from universities like Karolinska Institutet, University of Oxford, Utrecht University, Sorbonne University, and Università di Bologna use deidentified extracts for epidemiological modelling, burden-of-disease estimates, and assessments of interventions such as non-pharmaceutical interventions during the COVID-19 pandemic. Public health networks leverage outputs for cross-border response coordination with organisations such as European Civil Protection and Humanitarian Aid Operations and European Food Safety Authority for zoonotic and foodborne threats.

Governance, Privacy, and Security

Governance is provided by the governing body of the European Centre for Disease Prevention and Control under mandates from the European Union legal framework and data-sharing agreements negotiated with member states including Norway and Iceland. Privacy protections adopt principles aligned with the General Data Protection Regulation and national laws enforced by authorities like Data Protection Ombudsman offices in several capitals. Security measures include encrypted channels, role-based access controls, audit logs, and network protections influenced by standards from ENISA and cybersecurity practices promoted by European Commission initiatives.

Limitations and Criticisms

Critiques address timeliness and completeness of reporting from diverse national systems such as those in Bulgaria, Croatia, and Slovenia, variability in diagnostic capacity at reference laboratories like National Institute for Communicable Diseases counterparts, and challenges in linking clinical and laboratory data across jurisdictions. Methodological limitations include under-ascertainment, reporting delays during emergencies exemplified by the COVID-19 pandemic, and heterogeneity in case definitions despite harmonization efforts via World Health Organization guidance. Calls for improved transparency, broader access for independent researchers at institutions such as European University Institute and enhanced interoperability with electronic health records have been raised by public health scholars and policy analysts.

Category:Public health surveillance